Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/vaccines9030223 http://scihub22266oqcxt.onion/10.3390/vaccines9030223 33807647!8002114!33807647     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Vaccines+(Basel) 2021 ; 9 (3): ä Nephropedia Template TP {{tp|p=33807647|t=2021. Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China |pdf=|usr=}}{{33807647}} gab.com Text Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China JO: Vaccines (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=33807647 #FOAvip This study forecasts Coronavirus Disease 2019 (COVID-19) vaccination impact in two countries at different epidemic phases, the United States (US) and China. We assessed the impact of both a vaccine that prevents infection (VE(S) of 95%) and a vaccine that prevents only disease (VE(P) of 95%) through mathematical modeling. For VE(S) of 95% and gradual easing of restrictions, vaccination in the US reduced the peak incidence of infection, disease, and death by >55% and cumulative incidence by >32% and in China by >77% and >65%, respectively. Nearly three vaccinations were needed to avert one infection in the US, but only one was needed in China. For VE(P) of 95%, vaccination benefits were half those for VE(S) of 95%. In both countries, impact of vaccination was substantially enhanced with rapid scale-up, vaccine coverage >50%, and slower or no easing of restrictions, particularly in the US. COVID-19 vaccination can flatten, delay, and/or prevent future epidemic waves. However, vaccine impact is destined to be heterogeneous across countries because of an underlying "epidemiologic inequity" that reduces benefits for countries already at high incidence, such as the US. Despite 95% efficacy, actual vaccine impact could be meager in such countries if vaccine scale-up is slow, acceptance is poor, or restrictions are eased prematurely. Twit Text FOAVip Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China ????Vaccines (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=33807647 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33807647 #FOAvip English Wikipedia <ref>{{Cite pmid|33807647}}</ref> Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China #MMPMID33807647 Makhoul M; Chemaitelly H; Ayoub HH; Seedat S; Abu-Raddad LJ Vaccines (Basel) 2021[Mar]; 9 (3): ä PMID33807647show ga This study forecasts Coronavirus Disease 2019 (COVID-19) vaccination impact in two countries at different epidemic phases, the United States (US) and China. We assessed the impact of both a vaccine that prevents infection (VE(S) of 95%) and a vaccine that prevents only disease (VE(P) of 95%) through mathematical modeling. For VE(S) of 95% and gradual easing of restrictions, vaccination in the US reduced the peak incidence of infection, disease, and death by >55% and cumulative incidence by >32% and in China by >77% and >65%, respectively. Nearly three vaccinations were needed to avert one infection in the US, but only one was needed in China. For VE(P) of 95%, vaccination benefits were half those for VE(S) of 95%. In both countries, impact of vaccination was substantially enhanced with rapid scale-up, vaccine coverage >50%, and slower or no easing of restrictions, particularly in the US. COVID-19 vaccination can flatten, delay, and/or prevent future epidemic waves. However, vaccine impact is destined to be heterogeneous across countries because of an underlying "epidemiologic inequity" that reduces benefits for countries already at high incidence, such as the US. Despite 95% efficacy, actual vaccine impact could be meager in such countries if vaccine scale-up is slow, acceptance is poor, or restrictions are eased prematurely. äEpidemiological Differences in the Impact of COVID-19 Vaccination in t(epmc).pdf DeepDyve Pubget Overpricing